Back to results
US 7,402,656 B2Granted
PRO10013 polypeptides
AssigneeGenentech, Inc.
InventorsAudrey Goddard, Paul J. Godowski, Austin L. Gurney, Victoria Smith, William I. Wood
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel PRO10013 polypeptides chimeric polypeptide molecules comprising PRO10013 polypeptides fused to heterologous polypeptide sequences.
Claims5
An isolated polypeptide comprising:
- (a) the amino acid sequence of the polypeptide of SEQ ID NO:
- 34;
- or
- (b) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number PTA-1096,
- wherein said polypeptide is overexpressed in colon tumor cells.
2 more elements
Dependencies are inferred from the claim text.